StoxApollo Hospitals Enterprise vs Global Health: share price & financials comparison
NSE: APOLLOHOSP vs MEDANTA · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Apollo Hospitals Enterprise vs Global Health at a glance
Apollo Hospitals Enterprise (APOLLOHOSP) has a market capitalisation of ₹1,22,604 Cr, against ₹39,065 Cr for Global Health (MEDANTA). Over the past year Global Health has returned +16.4%, compared with +9.2% for Apollo Hospitals Enterprise. On valuation, Apollo Hospitals Enterprise trades at a lower P/E of 54.7 versus 98.2. Apollo Hospitals Enterprise earns a higher return on equity (21.1% vs 9.2%). Apollo Hospitals Enterprise comes out ahead on size, valuation, profitability and growth. Global Health comes out ahead on financial health, momentum and technicals. Across the scored metrics below, Apollo Hospitals Enterprise leads on 8 and Global Health on 8. On StoxGud's 10-point checklist, Apollo Hospitals Enterprise scores 7/10 and Global Health scores 6/10.
| Metric | Apollo Hospitals Enterprise | Global Health |
|---|---|---|
| Size | ||
| Market cap | ₹1,22,604 Cr | ₹39,065 Cr |
| Revenue (latest FY) | ₹25,228 Cr | ₹4,410 Cr |
| Net profit (latest FY) | ₹1,942 Cr | ₹556 Cr |
| Valuation | ||
| P/E | 54.7 | 98.2 |
| P/B | 11.56 | 9.04 |
| Dividend yield | 0.24% | 0.03% |
| Profitability | ||
| Return on equity | 21.1% | 9.2% |
| Net profit margin | 8.1% | 7.9% |
| Operating margin | 15.4% | 22.1% |
| Growth | ||
| Revenue growth (YoY) | +20.8% | +33.6% |
| Net profit growth (YoY) | +32.0% | -100.0% |
| Revenue CAGR (multi-year) | +19.0% | +17.9% |
| Financial health | ||
| Debt to equity | 0.53 | 0.16 |
| Momentum | ||
| 1-month return | +8.3% | +13.6% |
| 1-year return | +9.2% | +16.4% |
| 3-year CAGR | +17.8% | +16.9% |
| 5-year CAGR | +10.9% | — |
| 10-year CAGR | +21.8% | — |
| Distance from 52W high | -6.0% | -3.6% |
| Technicals | ||
| RSI (14) | 75 | 88 |
| Price vs 200-day avg | +4.6% | +15.9% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Apollo Hospitals Enterprise | Global Health |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 7/10 | 6/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Apollo Hospitals Enterprise or Global Health?
Apollo Hospitals Enterprise has a market cap of ₹1,22,604 Cr and Global Health has a market cap of ₹39,065 Cr as of 13 Nov 2026.
Which has a lower P/E, Apollo Hospitals Enterprise or Global Health?
Apollo Hospitals Enterprise has the lower P/E: Apollo Hospitals Enterprise trades at 54.7 and Global Health at 98.2.
Which gave better returns in the last year, Apollo Hospitals Enterprise or Global Health?
Global Health did better: Apollo Hospitals Enterprise returned +9.2% and Global Health returned +16.4% over one year.
What is the difference between Apollo Hospitals Enterprise and Global Health?
Both are NSE-listed companies in Healthcare. Apollo Hospitals Enterprise is about 3.1 times the size of Global Health by market cap. In the latest financial year Apollo Hospitals Enterprise reported revenue of ₹25,228 Cr and Global Health ₹4,410 Cr. Operating margin is 15.4% for Apollo Hospitals Enterprise and 22.1% for Global Health. Debt to equity is 0.53 for Apollo Hospitals Enterprise and 0.16 for Global Health.
Which is better, Apollo Hospitals Enterprise or Global Health?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Apollo Hospitals Enterprise leads on 8 and Global Health on 8. Apollo Hospitals Enterprise is ahead on size, valuation, profitability and growth. Global Health is ahead on financial health, momentum and technicals. On StoxGud's rules-based checklist Apollo Hospitals Enterprise scores 7/10 and Global Health scores 6/10. This is information, not advice: consult a SEBI-registered adviser before investing.